RecruitingNCT06342492
Conduction System Vs Surgical Left Ventricular Epicardial Pacing For Coronary Sinus Lead Failure
Sponsor
Kansas City Heart Rhythm Research Foundation
Enrollment
100 participants
Start Date
Nov 7, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This a single-center, retrospective, observational study of patients that undergo coronary sinus(CS) lead revision, comparing epicardial lead placement to coronary sinus pacing(CSP) in those that had lead failure.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- All patients older than 18 years of age
- Patients with HFrEF that underwent BVP-CRT
- Experienced CS lead failure, whether initial or recurrent, subsequently replaced with transthoracic epicardial lead placement or CSP
- Underwent Medtronic, Boston Scientific, or Abbott lead placement
Exclusion Criteria3
- Patients younger than 18 years of age
- Transthoracic epicardial lead placement or CSP performed as the initial approach or for other reasons than lead replacement
- Those for which CRT no longer provides symptom relief or mortality benefit.
Interventions
OTHERCoronary Sinus Lead Revision
Coronary Sinus Lead Revision
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06342492
Related Trials
Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System
NCT042377011 location
Digital Support Program for Patients With Heart Failure - a Cluster-Randomized Hybrid Type 2 Study
NCT072759311 location
Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy
NCT061289801 location
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
NCT06736574183 locations
Ketones, SGLT2, HFrEF
NCT062296781 location